Abstract
Ethambutol hydrochloride has been used in the treatment of tuberculosis for 25 years. Its only important adverse effect, retrobulbar neuritis, is thought to be a minor concern with conventional dosages. The author presents four cases of serious visual impairment due to ethambutol therapy. Three of the patients were receiving a maintenance dosage of 15 mg/kg per day. The fourth patient was inadvertently given 25 mg/kg per day for 4 months. After therapy with the drug was stopped, improvement was slow, with complete recovery in two cases and only minor residual changes in a third. The patient who received the higher dosage of ethambutol suffered permanent, marked impairment. Ethambutol appears to contribute little to modern short-course antituberculous regimens that include more potent agents such as isoniazid and rifampin. In view of this and the potential for serious visual impairment, alternative antituberculous agents should be considered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Addington W. W. The side effects and interactions of antituberculosis drugs. Chest. 1979 Dec;76(6 Suppl):782–784. doi: 10.1378/chest.76.6_supplement.782. [DOI] [PubMed] [Google Scholar]
- Boman G., Calissendorff B. A case of irreversible bilateral optic damage after ethambutol therapy. Scand J Respir Dis. 1974;55(3):176–180. [PubMed] [Google Scholar]
- Chatterjee V. K., Buchanan D. R., Friedmann A. I., Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest. 1986 Jul;80(3):288–291. doi: 10.1016/0007-0971(86)90066-5. [DOI] [PubMed] [Google Scholar]
- Citron K. M. Ethambutol: a review with special reference to ocular toxicity. Tubercle. 1969 Mar;50(Suppl):32–36. doi: 10.1016/0041-3879(69)90079-8. [DOI] [PubMed] [Google Scholar]
- Doster B., Murray F. J., Newman R., Woolpert S. F. Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials. Am Rev Respir Dis. 1973 Feb;107(2):177–190. doi: 10.1164/arrd.1973.107.2.177. [DOI] [PubMed] [Google Scholar]
- Fox W. The chemotherapy of pulmonary tuberculosis: a review. Chest. 1979 Dec;76(6 Suppl):785–796. doi: 10.1378/chest.76.6_supplement.785. [DOI] [PubMed] [Google Scholar]
- Jindani A., Aber V. R., Edwards E. A., Mitchison D. A. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980 Jun;121(6):939–949. doi: 10.1164/arrd.1980.121.6.939. [DOI] [PubMed] [Google Scholar]
- Leibold J. E. The ocular toxicity of ethambutol and its relation to dose. Ann N Y Acad Sci. 1966 Apr 20;135(2):904–909. doi: 10.1111/j.1749-6632.1966.tb45532.x. [DOI] [PubMed] [Google Scholar]
- Mitchison D. A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 1985 Sep;66(3):219–225. doi: 10.1016/0041-3879(85)90040-6. [DOI] [PubMed] [Google Scholar]
- Pyle M. M. Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation. Ann N Y Acad Sci. 1966 Apr 20;135(2):835–845. doi: 10.1111/j.1749-6632.1966.tb45526.x. [DOI] [PubMed] [Google Scholar]
- Schmidt I. G. Central nervous system effects of ethambutol in monkeys. Ann N Y Acad Sci. 1966 Apr 20;135(2):759–774. doi: 10.1111/j.1749-6632.1966.tb45521.x. [DOI] [PubMed] [Google Scholar]
- Shepherd R. G., Baughn C., Cantrall M. L., Goodstein B., Thomas J. P., Wilkinson R. G. Structure-activity studies leading to ethambutol, a new type of antituberculous compound. Ann N Y Acad Sci. 1966 Apr 20;135(2):686–710. doi: 10.1111/j.1749-6632.1966.tb45516.x. [DOI] [PubMed] [Google Scholar]